135 results
Page 5 of 7
8-K
EX-99.1
1locu dpqjds4ey
13 Feb 12
Anavex Closes Private Placement
12:00am
8-K
EX-99.1
s2w 7499ij
8 Dec 11
Anavex Closes Private Placement
12:00am
8-K
EX-99.1
nwh7xdiv7l
16 Nov 11
Anavex successfully completes a Phase 1 clinical trial for ANAVEX 2-73
12:00am
8-K
EX-99.1
fhdfdw646 w33
21 Oct 11
Anavex Announces Resignation of Director
12:00am
8-K
EX-99.1
hs8ha
14 Oct 11
Anavex appoints Dr. George Tidmarsh as Executive Director
12:00am
8-K
EX-99.1
jhvbnt1
21 Sep 11
Anavex announces director resignation
12:00am
8-K
EX-99.3
7rkucf7
3 Aug 11
Other Events
12:00am
8-K
EX-99.4
kf6fjgrqh8ci5h
3 Aug 11
Other Events
12:00am
8-K
EX-99.2
kv0t1vzw
3 Aug 11
Other Events
12:00am
8-K
EX-99.1
plw4lryjpr5ylq3ip6
3 Aug 11
Other Events
12:00am
8-K
EX-99.1
zns6 okvrul0qxo
9 Jun 11
Other Events
12:00am
8-K/A
EX-99.1
v4qeyp
10 May 11
Unregistered Sales of Equity Securities
12:00am
8-K
EX-99.1
n4p2kaiuer a2ekya
13 Apr 11
Anavex Appoints Dr. Christopher Shackleton as an Advisor
12:00am
8-K
EX-99.1
k3avrutrolnfrknjf
23 Mar 11
Anavex Receives Approval to Commence Phase I Clinical Trial In Alzheimer’s Disease
12:00am
8-K/A
EX-99.3
0ihblr2
4 Mar 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.2
48nodjrd5d78owoh7
28 Feb 11
Anavex Appoints DR. Rachelle Doody to Scientific Advisory Board
12:00am